SUBCUTANEOUS TOCILIZUMAB IN ADULTS WITH SYSTEMIC SCLEROSIS: 24 AND 48 WEEK SAFETY AND EFFICACY DATA FROM THE FASSCINATE TRIAL

被引：0
|
作者：
Denton, Christopher [1 ]
Khanna, Dinesh [2 ]
Jahreis, Angelika [3 ]
van Laar, Jacob M. [4 ]
Cheng, Sabrina [3 ]
Spotswood, Helen [5 ]
Pope, Janet E. [6 ]
Allanore, Yannick [7 ]
Mueller-Ladner, Ulf [8 ]
Siegel, Jeffrey [3 ]
Furst, Daniel E. [9 ]
机构：
[1] UCL, Sch Med, Mortimer St, London W1N 8AA, England
[2] Univ Michigan, Div Rheumatol, Ann Arbor, MI 48109 USA
[3] Genentech Inc, Rheumatol, San Francisco, CA 94080 USA
[4] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands
[5] Roche Prod Ltd, Rheumatol, Welwyn Garden City AL7 3AY, Herts, England
[6] St Josephs Hlth Care, Ctr Rheumatol, London, ON, Canada
[7] Paris Descartes Univ, Cochin Inst, Paris, France
[8] Univ Giessen, Kerckhoff Clin, Bad Nauheim, Germany
[9] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O27
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [31] Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
    Spiera, Robert
    Hummers, Laura
    Chung, Lorinda
    Frech, Tracy M.
    Domsic, Robyn
    Hsu, Vivien
    Furst, Daniel E.
    Gordon, Jessica
    Mayes, Maureen
    Simms, Robert
    Lafyatis, Robert
    Martyanov, Viktor
    Wood, Tammara
    Whitfield, Michael L.
    Constantine, Scott
    Lee, Elizabeth
    Dgetluck, Nancy
    White, Barbara
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1350 - 1360
  • [32] EFFICACY OF AN INTENSIVE 24-WEEK PHYSIOTHERAPY PROGRAMME IN PATIENTS WITH SYSTEMIC SCLEROSIS PRELIMINARY DATA FROM A SINGLE-CENTER CONTROLLED STUDY
    Spiritovic, M.
    Smucrova, H.
    Oreska, S.
    Storkanova, H.
    Cesak, P.
    Rathouska, A.
    Ruzickova, O.
    Mann, H.
    Pavelka, K.
    Senolt, L.
    Vencovsky, J.
    Becvar, R.
    Tomcik, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 638 - 639
  • [33] 5-YEAR DATA FROM TENDER, A PHASE III CLINICAL TRIAL: SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Baildam, Eileen
    De Benedetti, Fabrizio
    Ruperto, Nicola
    Brunner, Hermine
    Keane, Caroline
    Wells, Chris
    Wang, Jianmei
    Calvo, Inmaculada
    Cuttica, Ruben
    Ravelli, Angello
    Schneider, Rayfel
    Eleftheriou, Despina
    Wouters, Carine
    Xavier, Ricardo
    Zemel, Lawrence
    Burgos-Vargas, Ruben
    Dolezalova, Pavla
    Garay, Stella M.
    Joos, Rik
    Grom, Alexei
    Wulffraat, Nico
    Zuber, Zbyszek
    Zulian, Francesco
    Martini, Alberto
    Lovell, Daniel
    [J]. RHEUMATOLOGY, 2016, 55 : 56 - 56
  • [34] SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 5-YEAR DATA FROM TENDER, A PHASE 3 CLINICAL TRIAL
    De Benedetti, F.
    Ruperto, N.
    Brunner, H.
    Keane, C.
    Wells, C.
    Wang, J.
    Calvo, I.
    Cuttica, R.
    Ravelli, A.
    Schneider, R.
    Eleftheriou, D.
    Wouters, C.
    Xavier, R.
    Zemel, L.
    Baildam, E.
    Burgos-Vargas, R.
    Dolezalova, P.
    Garay, S. M.
    Joos, R.
    Grom, A.
    Wulffraat, N.
    Zuber, Z.
    Zulian, F.
    Martini, A.
    Lovell, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 384 - 384
  • [35] 24-Week efficacy and safety results from the adalimumab effectiveness in psoriatic arthritis trial (ADEPT)
    Mease, PJ
    Choy, EHS
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SD
    Weinberg, MA
    [J]. RHEUMATOLOGY, 2005, 44 : I3 - I3
  • [36] EFFICACY AND SAFETY OF TOCILIZUMAB IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS - DATA OF THE BIKER REGISTRY
    Klein, Ariane
    Ganser, Gerd
    Trauzeddel, Ralf
    Minden, Kisten
    Rietschel, Christoph
    Kuemmerle-Deschner, Jasmin
    Horneff, Gerd
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 969 - 969
  • [37] TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: EFFICACY DATA FROM THE PLACEBO-CONTROLLED 12-WEEK PART OF THE PHASE III TENDER TRIAL
    Chaitow, J.
    De Benedetti, F.
    Brunner, H.
    Ruperto, N.
    Allen, R.
    Murray, K.
    Schneider, R.
    Woo, P.
    Wright, S.
    Kenwright, A.
    Martini, A.
    Lovell, D.
    [J]. INTERNAL MEDICINE JOURNAL, 2011, 41 : 32 - 32
  • [38] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM A PHASE 3 TRIAL
    De Benedetti, F.
    Ruperto, N.
    Zuber, Z.
    Keane, C.
    Harari, O.
    Kenwright, A.
    Cuttica, R.
    Keltsev, V.
    Xavier, R.
    Calvo, I.
    Nikishina, I.
    Rubio-Perez, N.
    Alekseeva, E.
    Chasnyk, V.
    Chavez, J.
    Horneff, G.
    Opoka-Winiarska, V.
    Quartier, P.
    Silva, C.
    Silverman, E.
    Spindler, A.
    Martini, A.
    Lovell, D.
    Brunner, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 70 - 70
  • [39] Tocilizumab improves systemic and laboratory features of Systemic Juvenile Idiopathic Arthritis: 12-week data from the Phase 3 TENDER Trial
    De Benedetti, F.
    Rome, Bambin Gesu
    Ruperto, N.
    Brunner, H.
    Baildam, E.
    Burgos, R.
    Dolezalova, P.
    Garay, S.
    Garcia-Consuegra, J.
    Joos, R.
    Wulffraat, N.
    Zuber, Z.
    Zulian, F.
    Grom, A.
    Schaefer, F.
    Wright, S.
    Kenwright, A.
    Martini, A.
    Lovell, D.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 415 - 415
  • [40] CYCLOSPORINE IN SYSTEMIC-SCLEROSIS - RESULTS OF A 48-WEEK OPEN SAFETY STUDY IN 10 PATIENTS
    CLEMENTS, PJ
    LACHENBRUCH, PA
    STERZ, M
    DANOVITCH, G
    HAWKINS, R
    IPPOLITI, A
    PAULUS, HE
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (01): : 75 - 83
12345